Fabrizio Ceci

Pubblicazioni

Titolo Pubblicato in Anno
ANGPTL3 Deficiency and Risk of Hepatic Steatosis CIRCULATION 2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis CIRCULATION 2023
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients. risk factors and therapeutic implications THROMBOSIS JOURNAL 2022
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD) BIOMEDICINES 2021
DNA methylation patterns correlate with the expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial sodium channel, ENaC) genes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis JOURNAL OF CLINICAL LIPIDOLOGY 2021
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events. JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2021
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2020
Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2020
Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld) BIOMEDICINES 2020
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity PEDIATRIC RESEARCH 2019
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2019
Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2018
Severity of OSAS, CPAP and cardiovascular events: a follow-up study EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2018
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy SCIENTIFIC REPORTS 2018
Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease INTERNAL AND EMERGENCY MEDICINE 2017
Adherence to mediterranean diet and non-alcoholic fatty liver disease. effect on insulin resistance AMERICAN JOURNAL OF GASTROENTEROLOGY 2017
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage ATHEROSCLEROSIS 2017
Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2016

ERC

  • LS1_5
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Dislipidemie

Le dislipidemie rappresentano un gruppo di patologie estremamente complesse a causa dei numerosi geni coinvolti nella loro eziologia. Ciò rende difficile la loro caratterizzazione genetica e diagnosi. Nei pazienti con dislipidemia si analizza il pattern mutazionale dei geni LPL, ApoA1, PCSK9, LCAT, ABCA1 e LDL-R e si valuta l’effetto funzionale delle varianti rinvenute. Lo scopo è quello di migliorare la diagnostica genetica, la comprensione dei meccanismi molecolari alla base di questo gruppo di patologie e suoi risvolti terapeutici.

Dyslipidemias represent a group of extremely complex pathologies due to the numerous genes involved in their etiology. This makes their genetic characterization and diagnosis difficult. In patients with dyslipidemia, the mutational pattern of the LPL, ApoA1, PCSK9, LCAT, ABCA1 and LDL-R genes is analyzed and the functional effect of the variants found is evaluated. The aim is to improve genetic diagnostics, the understanding of the molecular mechanisms underlying this group of pathologies and its therapeutic implications.

Keywords

Lipids
cardiovascular diseases
cardiovascular risk factors
atherosclerosis
PCSK9 inhibitors

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma